Results 101 to 110 of about 8,099 (196)

Prognostic utility of blood inflammation biomarkers before and after treatment on the survival of patients with locally advanced non‐small cell lung cancer undergoing stereotactic body radiotherapy

The Clinical Respiratory Journal
Background and Objective The neutrophil–lymphocyte ratio (NLR) and platelet–lymphocyte ratio (PLR) were significant and succinct indicators of systemic inflammation.
Fang Fang, Zhen Jia, Hongliang Xie, Yangsen Cao, Xiaofei Zhu, Xiao Yu Yang, Xueling Guo, Huojun Zhang   +7 more
doaj   +1 more source

A new perspective on cancer treatment: the interaction and application prospect between ICIs and radiotherapy

Precision Radiation Oncology, Volume 10, Issue 2, Page 184-191, June 2026.
The combination of immune checkpoint inhibitors (ICIs) and radiotherapy synergistically enhances efficacy through an “antigen release‐immune activation” closed‐loop mechanism, significantly improving outcomes in solid tumors (e.g., lung cancer, melanoma).
Guiling Song, Lei Wang, Guopeng Zhao, Song Tan, Xin Liu, Xinghua Li   +5 more
wiley   +1 more source

Proton SBRT for Medically Inoperable Stage I NSCLC

, 2012
IntroductionThe physical properties of proton beam radiation may offer advantages for treating patients with non–small-cell lung cancer (NSCLC). However, its utility for the treatment of medically inoperable stage I NSCLC patients with stereotactic body ...
Lanuti, Michael, Willers, Henning, Martijn Engelsman, Michael Lanuti, Henning Willers, Adams, Judith A., Choi, Noah C., Judith A. Adams, Noah C. Choi, Westover, Kenneth D., Joao Seco, Engelsman, Martijn, Seco, Joao, Kenneth D. Westover   +13 more
core   +1 more source

Phase II clinical trial of robotic stereotactic body radiosurgery for metastatic gynecologic malignancies

Frontiers in Oncology, 2012
Background Recurrent gynecologic cancers are often difficult to manage without significant morbidity. We conducted a phase II study to assess the safety and the efficacy of ablative robotic stereotactic body radiosurgery (SBRT) in women with metastatic ...
Charles eKunos, James eBrindle, Steven eWaggoner, Kristine eZanotti, Kimberly eResnick, Nancy eFusco, Ramon eAdams, Robert eDebernardo   +7 more
doaj   +1 more source

Combining radiotherapy with CAR‐T cell therapy for solid tumors: Challenges, mechanisms, and future directions

Precision Radiation Oncology, Volume 10, Issue 2, Page 192-204, June 2026.
Radiotherapy enhances CAR‐Tcell therapy by increasing antigenicity, improving trafficking, and reshaping the tumor microenvironment. Despite its dual effects, including potential immune suppression, understanding these mechanisms enables the development of strategies to maximize synergy in solid tumors.
Leran Qiu, Xingyu Zhou, Jiao Xue, Xiaokang Zhang, Songbing Qin   +4 more
wiley   +1 more source

Dose-Escalated Robotic SBRT for Stage I-II Prostate Cancer

, 2015
: Stereotactic body radiotherapy (SBRT) is the precise external delivery of very high-dose radiotherapy to targets in the body, with treatment completed in one to five fractions. SBRT should be an ideal approach for organ-confined prostate cancer because
Robert eMeier, Robert Meier
core   +1 more source

Advances in mucosal injury mechanisms in radiation‐induced esophagitis associated with thoracic radiotherapy

Precision Radiation Oncology, Volume 10, Issue 2, Page 242-253, June 2026.
There is no specific therapeutic drug regimen for radiation esophagitis. In previous studies, radiation esophagitis was considered a self‐limiting disease; however, current clinical approaches are limited to symptomatic treatment, which yields unsatisfactory therapeutic outcomes.
Hao Zhang, Liangxue Luo, Chaofen Zhao, Bibo Wu, Jing Zhang, Lingfeng Liu, Bing Lu, Shengfa Su   +7 more
wiley   +1 more source

SBRT en el cáncer de pulmón [PDF]

, 2018
El cáncer de pulmón de células no pequeñas (CPCNP) representa el 85% de los cánceres de pulmón (CP) y alrededor de un 20% se diagnostica en estadios iniciales.
Martiño Córdoba, Rebeca Teresa, Corral Bote, Ana   +1 more
core  

A new perspective on radiotherapy in the comprehensive treatment of cancer

Precision Radiation Oncology, Volume 10, Issue 2, Page 165-183, June 2026.
Radiotherapy remains a key component in the comprehensive management of cancer. Its effectiveness is significantly improved through strategic combinations with chemotherapy, targeted therapy, and immunotherapy, providing a range of therapeutic outcomes from cure to palliative care.
Yingze Ma, Hongxuan Yu, Shijie Shang, Shixin Shan, Dawei Chen   +4 more
wiley   +1 more source

Lung Stereotactic Body Radiotherapy (SBRT): Challenging Scenarios and New Frontiers

Stereotactic Body Radiotherapy (SBRT) has emerged as a pivotal treatment modality for early-stage non-small cell lung cancer (NSCLC), offering highly precise, high-dose radiation delivery.
Emanuela Olmetto, Antonio Pontoriero, Paolo Borghetti, Marco Galaverni, Francesco Cuccia, Matteo Sepulcri, Emanuele Alì, Marianna Miele, Maria Alessia Zerella, Luca Boldrini, Serena Badellino, Ruggero Spoto   +11 more
core   +1 more source